Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866643 · ClinicalTrials.gov registry record · Phase 3
Labor and Delivery Implant Insertion: A Randomized Controlled Trial
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 95
- Enrollment target
NCT02866643: Completed Phase 3 study, sponsored by Stanford University.
NCT02866643 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02866643, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 95 participants
- Enrollment target
Study Summary
A barrier to initiating progestin contraceptives in the early postpartum period is the concern of interference with breastfeeding, specifically lactogenesis. In this trial, the investigators aim to describe the effects of immediate insertion of the contraceptive implant on breastfeeding. The investigators seek to examine the time to lactogenesis with immediate post-delivery insertion in delivery room versus insertion of a contraceptive implant in the postpartum ward prior to medical discharge. For this study, 82 consenting women will be randomized to immediate implant insertion (0-2 hours following delivery) in the delivery room or insertion of the implant following delivery in postpartum room and prior to medical discharge (24-48 hours following delivery). Participants complete a questionnaire that asks questions about breastfeeding continuation, supplementation, duration, and exclusivity. This questionnaire also includes questions about contraceptive continuation, patient satisfaction with implant, pregnancy, and postpartum care visits.
Interventions
- DRUG Etonogestrel-Immediate
- DRUG Etonogestrel-Delayed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-10-28 |
| Est. Completion | 2021-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02866643
The ClinicalTrials.gov registry entry for NCT02866643 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Etonogestrel-Immediate is the first listed.
NCT02866643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02866643 about?
NCT02866643 is a clinical study titled "Labor and Delivery Implant Insertion: A Randomized Controlled Trial". A barrier to initiating progestin contraceptives in the early postpartum period is the concern of interference with breastfeeding, specifically lactogenesis. In this trial, the investigators aim to describe the effects of immediate insertion of the contraceptive implant on breastfeeding. The investi...
What is the current status of trial NCT02866643?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 95 participants. The study started on 2016-10-28. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT02866643?
The interventions under investigation include: Etonogestrel-Immediate (DRUG), Etonogestrel-Delayed (DRUG).
Who is sponsoring clinical trial NCT02866643?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.